Found: 8
Select item for more details and to access through your institution.
Correction to: Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 1, p. 57, doi. 10.1007/s40121-023-00896-w
- By:
- Publication type:
- Article
Development and Validation of a Reporter-Cell-Line-Based Bioassay for Therapeutic Soluble gp130-Fc.
- Published in:
- Molecules, 2019, v. 24, n. 21, p. 3845, doi. 10.3390/molecules24213845
- By:
- Publication type:
- Article
A Cell-Based Strategy for Bioactivity Determination of Long-Acting Fc-Fusion Recombinant Human Growth Hormone.
- Published in:
- Molecules, 2019, v. 24, n. 7, p. 1389, doi. 10.3390/molecules24071389
- By:
- Publication type:
- Article
Identification of a Recombinant Human Interleukin-12 (rhIL-12) Fragment in Non-Reduced SDS-PAGE.
- Published in:
- Molecules, 2019, v. 24, n. 7, p. 1210, doi. 10.3390/molecules24071210
- By:
- Publication type:
- Article
Bioactivity Determination of a Therapeutic Recombinant Human Keratinocyte Growth Factor by a Validated Cell-based Bioassay.
- Published in:
- Molecules, 2019, v. 24, n. 4, p. 699, doi. 10.3390/molecules24040699
- By:
- Publication type:
- Article
Magnesium Hydride Confers Osmotic Tolerance in Mung Bean Seedlings by Promoting Ascorbate–Glutathione Cycle.
- Published in:
- Plants (2223-7747), 2024, v. 13, n. 19, p. 2819, doi. 10.3390/plants13192819
- By:
- Publication type:
- Article
Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2.
- Published in:
- Cell Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41421-022-00517-9
- By:
- Publication type:
- Article